Pharma.Aero has announced Dachser and SkyCell as the newest additions to the global life sciences collaborative platform.
Dachser and SkyCell join Pharma.Aero’s global community of over 50 life science and MedTech supply chain stakeholders.
Frank Van Gelder, Secretary General of Pharma.Aero, welcomed the newest additions: “Pharma.Aero continues to expand its global presence by onboarding two companies with strong development and activity in life science logistics. By including Dachser in our group of full members and SkyCell in the group of associate partners, Pharma.Aero further strengthens its knowledge within the life sciences supply chain and logistics.”
Dachser is a global leader in system logistics, with 379 locations in 41 countries, and some 32,850 employees worldwide. The family-owned company, with headquarters in Germany, can draw on a network of 140 air and sea freight locations, has Pharma CEIV-certified locations on three continents and over 400 GDP-trained LSH specialists.
Netka Hohlfeld, Department Head Life Science and Healthcare Logistics at Dachser, underlines the vision and values Dachser and Pharma.Aero shared: “The life sciences and healthcare industry is experiencing an accelerated supply chain transformation; an increased need for efficiency, differentiation and access to new geographies; it is being challenged to enable digital supply chain solutions.”
“We as Dachser understand the undertaking and strive to be ready to help navigate the challenges and opportunities of the healthcare landscape through a holistic range of patient-centric, forward-thinking, intelligent healthcare logistics solutions. Dachser aims at being strongly involved in the Pharma.Aero community. With the membership, industry requirements and potential challenges can be thoroughly investigated.”
SkyCell is a Swiss-based, award-winning provider of temperature-controlled container solutions with a special focus on serving global pharma companies and sustainability. SkyCell brings together big data, software and hardware to transform an ever-evolving supply chain, to enable a market-leading failure rate of less than 0.1%, whilst also reducing CO2 emissions by almost half. Designed with sustainability as a core principle, SkyCell is climate-neutral today and has committed to the goal of end-to-end net-zero emissions by 2040.
Chiara Venuti, Head of Strategic Partnerships at SkyCell, highlighted the importance of collaboration across the industry: “I see this partnership with Pharma.Aero as a great opportunity to champion projects, share information and come together as an industry to create a seamless logistics network for our customers. Our commitment to safe, secure and sustainable temperature-controlled container solutions aligns perfectly with Pharma.Aero’s mission to enhance excellence in the pharma supply chain. We look forward to collaborating with Pharma.Aero and its members to develop industry standards and best practices for the life sciences and MedTech sector.“